documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
87 rows where agency_id = "FDA", document_type = "Rule" and posted_year = 2010 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_end_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2010-N-0002-0088 | FDA | FDA-2010-N-0002 | New Animal Drugs: Deslorelin | Rule | NFR-Notice of Final Rule | 2010-12-28T05:00:00Z | 2010 | 12 | 2010-12-28T05:00:00Z | 2010-12-28T15:43:43Z | 2010-32554 | 0 | 0 | 0900006480bc0c09 | |
| FDA-2010-N-0002-0087 | FDA | FDA-2010-N-0002 | New Animal Drugs; Change of Sponsor's Address | Rule | NFR-Notice of Final Rule | 2010-12-21T05:00:00Z | 2010 | 12 | 2010-12-21T05:00:00Z | 2010-12-21T14:31:22Z | 2010-31952 | 0 | 0 | 0900006480bbcc1e | |
| FDA-2010-N-0002-0085 | FDA | FDA-2010-N-0002 | New Animal Drugs: Mupirocin | Rule | NFR-Notice of Final Rule | 2010-12-20T05:00:00Z | 2010 | 12 | 2010-12-20T05:00:00Z | 2010-12-20T14:51:05Z | 2010-31870 | 0 | 0 | 0900006480bba052 | |
| FDA-2000-N-0011-0006 | FDA | Uniform Compliance Date for Food Labeling Regulations FDA-2000-N-0011 | Uniform Compliance Date for Food Labeling Regulations | Rule | NFR-Notice of Final Rule | 2010-12-15T05:00:00Z | 2010 | 12 | 2010-12-15T05:00:00Z | 2011-02-15T04:59:59Z | 2010-12-16T16:05:14Z | 2010-31382 | 0 | 0 | 0900006480bb6fad |
| FDA-2010-N-0002-0081 | FDA | FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Tylosin | Rule | NFR-Notice of Final Rule | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T05:00:00Z | 2010-12-08T15:43:21Z | 2010-30814 | 0 | 0 | 0900006480bb1e23 | |
| FDA-2010-N-0002-0083 | FDA | FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Flunixin | Rule | NFR-Notice of Final Rule | 2010-12-08T05:00:00Z | 2010 | 12 | 2010-12-08T05:00:00Z | 2010-12-08T16:18:02Z | 2010-30769 | 0 | 0 | 0900006480bb1ea7 | |
| FDA-2010-N-0560-0002 | FDA | FDA-2010-N-0560 | Amendments to General Regulations of Food and Drug Administration | Rule | NFR-Notice of Final Rule | 2010-11-30T05:00:00Z | 2010 | 11 | 2010-11-30T05:00:00Z | 2011-02-15T04:59:59Z | 2011-06-11T16:28:39Z | 2010-30039 | 0 | 0 | 0900006480ba9048 |
| FDA-2010-N-0002-0080 | FDA | FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor's Name and Address | Rule | NFR-Notice of Final Rule | 2010-11-26T05:00:00Z | 2010 | 11 | 2010-11-26T05:00:00Z | 2024-11-07T22:30:37Z | 2010-29693 | 1 | 0 | 0900006480ba43cf | |
| FDA-2010-N-0002-0079 | FDA | FDA-2010-N-0002 | Intramammary Dosage Form New Animal Drugs: Cloxacillin Benzathine | Rule | NFR-Notice of Final Rule | 2010-11-22T05:00:00Z | 2010 | 11 | 2010-11-22T05:00:00Z | 2024-11-07T22:25:26Z | 2010-29326 | 1 | 0 | 0900006480ba0922 | |
| FDA-2010-N-0513-0001 | FDA | FDA-2010-N-0513 | Medical Devices; General and Plastic Surgery Devices: Classification of Non-Powered Suction Apparatus Device Intended for NegativePressure Wound Therapy | Rule | NFR-Notice of Final Rule | 2010-11-17T05:00:00Z | 2010 | 11 | 2010-11-17T21:39:49Z | 2010-28873 | 0 | 0 | 0900006480b954fb | ||
| FDA-2010-N-0534-0002 | FDA | FDA-2010-N-0534 | New Animal Drugs for Minor Use and Minor Species | Rule | NFR-Notice of Final Rule | 2010-11-15T05:00:00Z | 2010 | 11 | 2010-11-15T05:00:00Z | 2011-02-01T04:59:59Z | 2024-11-12T04:55:47Z | 2010-28550 | 1 | 0 | 0900006480b88cdc |
| FDA-2010-N-0002-0078 | FDA | FDA-2010-N-0002 | New Animal Drugs; Change of Sponsor: Sulfadiazine and Pyrimethamine Suspension | Rule | NFR-Notice of Final Rule | 2010-11-15T05:00:00Z | 2010 | 11 | 2010-11-15T17:45:37Z | 2010-28549 | 0 | 0 | 0900006480b88cdb | ||
| FDA-2010-N-0002-0077 | FDA | FDA-2010-N-0002 | New Animal Drugs; Change of Sponsors Name | Rule | CEP-Certificate Extending Patent Term | 2010-11-10T05:00:00Z | 2010 | 11 | 2010-11-10T05:00:00Z | 2010-11-10T15:57:56Z | 2010-28307 | 0 | 0 | 0900006480b86258 | |
| FDA-2010-N-0512-0001 | FDA | FDA-2010-N-0512 | Medical Devices; General and Plastic Surgery Devices: Classification of Tissue Adhesive With Adjunct Wound Closure Device Intended for Topical Approximation of Skin | Rule | CEP-Certificate Extending Patent Term | 2010-11-10T05:00:00Z | 2010 | 11 | 2010-11-10T05:00:00Z | 2012-09-27T02:01:12Z | 2010-28356 | 0 | 0 | 0900006480b861ad | |
| FDA-2008-N-0273-0018 | FDA | FDA-2008-N-0273 | Medical Devices: Radiology Devices; Reclassification of Full-Field Digital Mammography System | Rule | NFR-Notice of Final Rule | 2010-11-05T04:00:00Z | 2010 | 11 | 2010-11-05T17:36:15Z | 2010-28007 | 0 | 0 | 0900006480b8254d | ||
| FDA-2010-N-0002-0075 | FDA | FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Domperidone | Rule | NFR-Notice of Final Rule | 2010-11-01T04:00:00Z | 2010 | 11 | 2010-11-01T15:15:29Z | 2010-27524 | 0 | 0 | 0900006480b7c883 | ||
| FDA-2010-N-0002-0074 | FDA | FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor; Monensin Blocks | Rule | NFR-Notice of Final Rule | 2010-10-28T04:00:00Z | 2010 | 10 | 2010-10-28T15:36:14Z | 2010-27287 | 0 | 0 | 0900006480b79676 | ||
| FDA-2010-N-0002-0073 | FDA | FDA-2010-N-0002 | Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran | Rule | NFR-Notice of Final Rule | 2010-10-26T04:00:00Z | 2010 | 10 | 2010-10-26T14:48:15Z | 2010-27011 | 0 | 0 | 0900006480b7753a | ||
| FDA-2010-N-0002-0071 | FDA | FDA-2010-N-0002 | Certain Other Dosage Form New Animal Drugs: Progesterone Intravaginal Inserts | Rule | NFR-Notice of Final Rule | 2010-10-14T04:00:00Z | 2010 | 10 | 2010-10-14T17:22:27Z | 2010-25893 | 0 | 0 | 0900006480b6eed0 | ||
| FDA-1981-N-0299-0007 | FDA | Milk & Cream; Identity Standards FDA-1981-N-0299 | Order to Revise Existing Standards and Establishment of New Identity Standards; Final Rule | Rule | NFR-Notice of Final Rule | 2010-10-12T04:00:00Z | 2010 | 10 | 2010-10-12T04:00:00Z | 1973-11-10T04:59:59Z | 2010-10-12T22:36:48Z | 0 | 0 | 09000064805b14b7 | |
| FDA-2010-N-0002-0069 | FDA | FDA-2010-N-0002 | Implantation and Injectable Dosage Form New Animal Drugs: Ceftiofur Crystalline Free Acid; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-10-12T04:00:00Z | 2010 | 10 | 2010-10-12T04:00:00Z | 2010-10-12T15:25:22Z | 2010-25527 | 0 | 0 | 0900006480b6c491 | |
| FDA-1982-F-0155-0002 | FDA | Direct Food Additives: Food Additives Permitted for Direct Addition to Food for Human Consuption; Dimethyl Dicarbonate FDA-1982-F-0155 | Direct Food Additives: Food Additives Permitted For Direct Addition To Food For Human Consumption; Dimethyl Dicarbonate | Rule | NFR-Notice of Final Rule | 2010-10-07T04:00:00Z | 2010 | 10 | 2010-10-07T04:00:00Z | 1988-11-22T04:59:59Z | 2010-10-07T15:25:08Z | 0 | 0 | 090000648050f626 | |
| FDA-2010-N-0002-0066 | FDA | FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs; Dexmedetomidine | Rule | NFR-Notice of Final Rule | 2010-09-30T04:00:00Z | 2010 | 9 | 2010-09-30T04:00:00Z | 2010-09-30T15:28:17Z | 2010-24494 | 0 | 0 | 0900006480b64109 | |
| FDA-2010-N-0002-0068 | FDA | FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds; Melengestrol | Rule | NFR-Notice of Final Rule | 2010-09-30T04:00:00Z | 2010 | 9 | 2010-09-30T04:00:00Z | 2010-09-30T15:42:59Z | 2010-24480 | 0 | 0 | 0900006480b64158 | |
| FDA-2000-N-0108-0071 | FDA | Safety Reporting Requirements Human Drug/Biological Products - CLOSED FDA-2000-N-0108 | Final Rule re Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products: Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans | Rule | Final Rule | 2010-09-29T04:00:00Z | 2010 | 9 | 2010-09-29T04:00:00Z | 2016-02-24T19:19:31Z | 2010-24296 | 0 | 0 | 0900006480b63055 | |
| FDA-2010-N-0002-0064 | FDA | FDA-2010-N-0002 | Implantation and Injectable Dosage Form New Animal Drugs: Firocoxib | Rule | NFR-Notice of Final Rule | 2010-09-28T04:00:00Z | 2010 | 9 | 2010-09-28T04:00:00Z | 2010-09-28T14:58:35Z | 2010-24254 | 0 | 0 | 0900006480b62263 | |
| FDA-2009-N-0344-0003 | FDA | FDA-2009-N-0344 | Microbiology Devices: Reclassification of Herpes Simplex Virus Types 1 and 2 Serological Assays; Confirmation of Effective Date | Rule | NCD-Notice of Confirmation of Effective Date | 2010-09-28T04:00:00Z | 2010 | 9 | 2010-09-28T04:00:00Z | 2010-09-28T14:23:52Z | 2010-23638 | 0 | 0 | 0900006480b62224 | |
| FDA-2010-N-0002-0063 | FDA | FDA-2010-N-0002 | Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Chloramphenicol; Lincomycin;Pyrantel Tartrate; and Tylosin Phosphate and Sulfamethazine | Rule | NFR-Notice of Final Rule | 2010-09-14T04:00:00Z | 2010 | 9 | 2010-09-14T15:22:40Z | 2010-22808 | 0 | 0 | 0900006480b4ea9e | ||
| FDA-1997-N-0011-0047 | FDA | Human Cellular and Tissue-Based Products FDA-1997-N-0011 | Notice of Final Rule re Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing | Rule | Final Rule | 2010-09-10T04:00:00Z | 2010 | 9 | 2010-09-10T04:00:00Z | 2016-01-14T18:25:10Z | 0 | 0 | 09000064805c9af7 | ||
| FDA-2000-P-0924-0002 | FDA | PTCA Balloon Catheters (74LOX) FDA-2000-P-0924 | Final Rule- Cardiovascular Devices: Reclassification of Certain Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters | Rule | NFR-Notice of Final Rule | 2010-09-08T04:00:00Z | 2010 | 9 | 2010-09-08T04:00:00Z | 2024-08-08T16:30:24Z | 2010-22304 | 0 | 0 | 0900006480b48181 | |
| FDA-2010-N-0002-0062 | FDA | FDA-2010-N-0002 | Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Ophthalmic Solution; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-09-08T04:00:00Z | 2010 | 9 | 2010-09-08T04:00:00Z | 2010-09-09T15:50:59Z | 2010-22276 | 0 | 0 | 0900006480b48200 | |
| FDA-2010-N-0002-0061 | FDA | FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Tiamulin | Rule | NFR-Notice of Final Rule | 2010-09-08T04:00:00Z | 2010 | 9 | 2010-09-08T04:00:00Z | 2010-09-09T16:00:35Z | 2010-22277 | 0 | 0 | 0900006480b481aa | |
| FDA-2010-N-0002-0056 | FDA | FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor's Name and Address | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T04:00:00Z | 2010-09-03T14:51:56Z | 2010-22044 | 0 | 0 | 0900006480b4490f | |
| FDA-2010-N-0002-0057 | FDA | FDA-2010-N-0002 | New Animal Drugs; Change of Sponsor: Penicillin G Benzathine and Penicillin G Procaine Suspension; Penicillin G Procaine Aqueous Suspension | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T04:00:00Z | 2010-09-03T15:04:07Z | 2010-22042 | 0 | 0 | 0900006480b449d2 | |
| FDA-2010-N-0002-0052 | FDA | FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feed: Ractopamine | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T04:00:00Z | 2010-09-03T14:36:56Z | 2010-22071 | 0 | 0 | 0900006480b444d4 | |
| FDA-2010-N-0002-0054 | FDA | FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Florfenicol and Flunixin | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T14:45:33Z | 2010-22039 | 0 | 0 | 0900006480b444ef | ||
| FDA-2010-N-0002-0058 | FDA | FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Praziquantel and Pyrantel | Rule | NFR-Notice of Final Rule | 2010-09-03T04:00:00Z | 2010 | 9 | 2010-09-03T04:00:00Z | 2010-09-03T15:07:38Z | 2010-22043 | 0 | 0 | 0900006480b449d4 | |
| FDA-2010-N-0002-0051 | FDA | FDA-2010-N-0002 | New Animal Drugs; Changes of Sponsors; Withdrawals of Approvals of New Animal Drug Applications: Deslorelin Acetate; Dichlorophene and Toluene Capsules; Pyrantel Pamoate Suspension | Rule | CEP-Certificate Extending Patent Term | 2010-08-27T04:00:00Z | 2010 | 8 | 2010-08-27T04:00:00Z | 2010-08-27T13:34:20Z | 2010-21296 | 0 | 0 | 0900006480b3c459 | |
| FDA-1993-N-0150-0002 | FDA | Financial Disclosure by Clinical Investigators FDA-1993-N-0150 | Financial Disclosure by Clinical Investigators; Correction | Rule | NCR-Notice of Correction | 2010-07-27T04:00:00Z | 2010 | 7 | 2010-07-27T04:00:00Z | 2010-07-27T20:52:38Z | 0 | 0 | 09000064804ff2da | ||
| FDA-2009-N-0458-0010 | FDA | FDA-2009-N-0458 | Medical Devices; Pediatric Uses of Devices; Requirements for Submission of Information, etc.: Withdrawal | Rule | NWL-Notice of Withdrawl | 2010-07-20T04:00:00Z | 2010 | 7 | 2011-06-11T16:28:04Z | 2010-17617 | 0 | 0 | 0900006480b1cf7d | ||
| FDA-1990-F-0131-0002 | FDA | Formaldehyde as a Antimicrobial Additive to Animal Feeds FDA-1990-F-0131 | Food Additives Permitted in Feed and Drinking Water of Animals; Formaldehyde; Final Rule | Rule | NFR-Notice of Final Rule | 2010-07-06T04:00:00Z | 2010 | 7 | 2010-07-06T04:00:00Z | 1996-05-10T03:59:59Z | 2010-09-21T01:16:03Z | 0 | 0 | 090000648052cfa0 | |
| FDA-2010-N-0002-0048 | FDA | FDA-2010-N-0002 | Implantations or Injectable Dosages Form New Animal Drugs: Propofol | Rule | NFR-Notice of Final Rule | 2010-07-06T04:00:00Z | 2010 | 7 | 2010-07-06T15:44:47Z | 2010-16301 | 0 | 0 | 0900006480b13970 | ||
| FDA-2010-N-0010-0005 | FDA | FDA-2010-N-0010 | Change of Address; Abbreviated New Drug Applications; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-06-29T04:00:00Z | 2010 | 6 | 2010-06-29T13:41:29Z | 2010-15711 | 0 | 0 | 0900006480b0c81f | ||
| FDA-2008-C-0098-0006 | FDA | FDA-2008-C-0098 | Listing of Color Additives Exempt from Certification: Bismuth Citrate; Confirmation of Effective Date | Rule | NCD-Notice of Confirmation of Effective Date | 2010-06-17T04:00:00Z | 2010 | 6 | 2010-10-29T01:09:59Z | 2010-14598 | 0 | 0 | 0900006480b03b70 | ||
| FDA-2010-N-0002-0045 | FDA | FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Florfenicol | Rule | NFR-Notice of Final Rule | 2010-06-17T04:00:00Z | 2010 | 6 | 2010-10-29T01:10:45Z | 2010-14611 | 0 | 0 | 0900006480b03b6f | ||
| FDA-2008-N-0163-0294 | FDA | FDA-2008-N-0163 | Dental Devices: Classification of Dental Amalgam, Reclassification of Dental Mercury, Designation of Special Controls for Dental Amalgam, Mercury, and Amalgam Alloy; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-06-11T04:00:00Z | 2010 | 6 | 2011-06-11T16:27:42Z | 2010-14083 | 0 | 0 | 0900006480b002a6 | ||
| FDA-2010-N-0010-0004 | FDA | FDA-2010-N-0010 | Change of Contact Information; Technical Amendment | Rule | N-Notice | 2010-06-09T04:00:00Z | 2010 | 6 | 2010-06-09T04:00:00Z | 2010-06-09T16:29:08Z | 2010-13820 | 0 | 0 | 0900006480afeb5e | |
| FDA-2010-N-0002-0041 | FDA | FDA-2010-N-0002 | Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution | Rule | NFR-Notice of Final Rule | 2010-05-12T04:00:00Z | 2010 | 5 | 2010-05-12T04:00:00Z | 2010-05-12T13:53:44Z | 2010-11244 | 0 | 0 | 0900006480aebea3 | |
| FDA-2010-N-0002-0039 | FDA | FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin | Rule | NFR-Notice of Final Rule | 2010-05-12T04:00:00Z | 2010 | 5 | 2010-05-12T04:00:00Z | 2010-05-12T13:37:48Z | 2010-11282 | 0 | 0 | 0900006480aebe42 | |
| FDA-2010-N-0002-0043 | FDA | FDA-2010-N-0002 | Oral Dosages Form New Animal Drugs: Orbifloxacin Suspension | Rule | NFR-Notice of Final Rule | 2010-05-12T04:00:00Z | 2010 | 5 | 2010-05-12T04:00:00Z | 2010-05-12T14:14:28Z | 2010-11245 | 0 | 0 | 0900006480aebeee | |
| FDA-2010-N-0002-0038 | FDA | FDA-2010-N-0002 | Animal Drugs, Feeds, and Related Products: Withdrawal of Approval of a New Animal Drug Application; Buquinolate; Coumaphos | Rule | NFR-Notice of Final Rule | 2010-05-05T04:00:00Z | 2010 | 5 | 2010-05-05T04:00:00Z | 2010-05-05T18:21:18Z | 2010-10564 | 0 | 0 | 0900006480ae7219 | |
| FDA-1992-N-0132-0001 | FDA | Food & Color Additives; Recognized as Safe Subs; Tech Amends FDA-1992-N-0132 | Food and Color Additives; Generally Recognized As Safe Substances; Technical Amendments | Rule | Final Rule | 2010-04-30T04:00:00Z | 2010 | 4 | 2010-04-30T04:00:00Z | 2023-09-20T12:50:19Z | 92-7106 | 0 | 0 | 090000648052dbd3 | |
| FDA-1986-F-0378-0002 | FDA | Ethylene Vinyl Acetate Copolymers as Packaging Material-CLOSED FDA-1986-F-0378 | Irradiation In The Production, Processing, and Handling of Foods | Rule | Final Rule | 2010-04-30T04:00:00Z | 2010 | 4 | 2010-04-30T04:00:00Z | 1989-03-24T04:59:59Z | 2023-02-10T17:02:33Z | 89-3864 | 0 | 0 | 09000064805110a0 |
| FDA-2010-N-0002-0035 | FDA | FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Butorphanol | Rule | NFR-Notice of Final Rule | 2010-04-29T04:00:00Z | 2010 | 4 | 2010-04-29T14:05:53Z | 2010-09871 | 0 | 0 | 0900006480ae39a6 | ||
| FDA-2010-N-0002-0032 | FDA | FDA-2010-N-0002 | Certain Other Dosage Form New Animal Drugs; Detomidine | Rule | NFR-Notice of Final Rule | 2010-04-23T04:00:00Z | 2010 | 4 | 2010-04-23T15:05:24Z | 2010-09371 | 0 | 0 | 0900006480ade6c3 | ||
| FDA-2010-N-0010-0003 | FDA | FDA-2010-N-0010 | Center for Devices and Radiological Health; New Address Information | Rule | NFR-Notice of Final Rule | 2010-04-22T04:00:00Z | 2010 | 4 | 2010-04-22T14:01:49Z | 2010-08863 | 0 | 0 | 0900006480adcfd6 | ||
| FDA-2010-N-0002-0030 | FDA | FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Melengestrol, Monensin, and Ractopamine | Rule | NFR-Notice of Final Rule | 2010-04-22T04:00:00Z | 2010 | 4 | 2010-04-22T13:40:34Z | 2010-09304 | 0 | 0 | 0900006480adcfba | ||
| FDA-2010-N-0002-0028 | FDA | FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor | Rule | NFR-Notice of Final Rule | 2010-04-20T04:00:00Z | 2010 | 4 | 2010-04-20T04:00:00Z | 2024-11-12T04:53:46Z | 2010-09057 | 1 | 0 | 0900006480adba4f | |
| FDA-2010-N-0002-0029 | FDA | FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor | Rule | NFR-Notice of Final Rule | 2010-04-20T04:00:00Z | 2010 | 4 | 2010-04-20T04:00:00Z | 2024-11-12T04:53:58Z | 2010-09045 | 1 | 0 | 0900006480adbad7 | |
| FDA-2010-N-0002-0027 | FDA | FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Change of Sponsor; Propofol | Rule | NFR-Notice of Final Rule | 2010-04-19T04:00:00Z | 2010 | 4 | 2010-04-19T04:00:00Z | 2024-11-07T22:17:54Z | 2010-08945 | 1 | 0 | 0900006480adaf52 | |
| FDA-2006-N-0304-0039 | FDA | Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 | Use of Ozone-Depleting Substances; Removal of Essential-Use Designation: Flunisolide, etc. | Rule | NFR-Notice of Final Rule | 2010-04-14T04:00:00Z | 2010 | 4 | 2010-04-14T04:00:00Z | 2011-06-11T16:25:59Z | 2010-08467 | 0 | 0 | 0900006480ad7218 | |
| FDA-2000-N-0190-0110 | FDA | Egg Safety Action Plan FDA-2000-N-0190 | Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation, etc.; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-04-13T04:00:00Z | 2010 | 4 | 2010-04-13T14:28:09Z | 2010-08358 | 0 | 0 | 0900006480ad65c5 | ||
| FDA-1975-N-0017-0050 | FDA | OTC Nighttime Sleep-Aid, Daytime Sedative, & Stimulant Products-CLOSED FDA-1975-N-0017 | See FDA-1975-N-0017-0028 | Rule | NFR-Notice of Final Rule | 2010-04-09T04:00:00Z | 2010 | 4 | 2010-04-09T04:00:00Z | 2011-02-08T14:46:37Z | 0 | 0 | 0900006480ad3b5e | ||
| FDA-1999-N-3539-0001 | FDA | Administrative Practices & Procedures;Good Guidance Practice FDA-1999-N-3539 | Technical Amendments: Administrative Practices and Procedures; Good Guidance Practices | Rule | Final Rule | 2010-04-01T04:00:00Z | 2010 | 4 | 2015-11-10T15:50:14Z | 2010-07286 | 0 | 0 | 0900006480ace273 | ||
| FDA-2009-N-0458-0002 | FDA | FDA-2009-N-0458 | Medical Devices; Pediatric Uses of Devices: Requirement for Submission of Information on Pediatric Subpopulations That Suffer From a Disease, et al. | Rule | NFR-Notice of Final Rule | 2010-04-01T04:00:00Z | 2010 | 4 | 2010-04-01T04:00:00Z | 2010-06-16T03:59:59Z | 2011-06-11T16:28:04Z | 2010-07193 | 0 | 0 | 0900006480ace1bb |
| FDA-2010-N-0010-0002 | FDA | FDA-2010-N-0010 | Technical Amendments: Medical Devices | Rule | NFR-Notice of Final Rule | 2010-04-01T04:00:00Z | 2010 | 4 | 2010-04-01T15:59:32Z | 2010-07288 | 0 | 0 | 0900006480ace17c | ||
| FDA-2010-N-0002-0025 | FDA | FDA-2010-N-0002 | Ophthalmic and Topical Dosage Form New Animal Drugs: Orbifloxacin, Mometasone Furoate Monohydrate, and Posaconazole Suspension | Rule | NFR-Notice of Final Rule | 2010-04-01T04:00:00Z | 2010 | 4 | 2010-04-01T16:05:18Z | 2010-07163 | 0 | 0 | 0900006480ace19b | ||
| FDA-2010-N-0148-0001 | FDA | FDA-2010-N-0148 | Revision of Organization and Conforming Changes to Regulations | Rule | NFR-Notice of Final Rule | 2010-04-01T04:00:00Z | 2010 | 4 | 2010-04-01T15:54:52Z | 2010-07282 | 0 | 0 | 0900006480ace164 | ||
| FDA-2003-N-0446-0027 | FDA | New Animal Drugs; Removal of Obsolete and Redundant Regulations - CLOSED FDA-2003-N-0446 | New Animal Drugs: Removal of Obsolete and Redundant Regulations | Rule | NFR-Notice of Final Rule | 2010-03-31T04:00:00Z | 2010 | 3 | 2010-03-31T04:00:00Z | 2010-03-31T18:16:34Z | 2010-07108 | 0 | 0 | 0900006480acd296 | |
| FDA-2003-N-0446-0026 | FDA | New Animal Drugs; Removal of Obsolete and Redundant Regulations - CLOSED FDA-2003-N-0446 | New Animal Drugs for Use in Animal Feeds; CFR Correction | Rule | CFR-Correction | 2010-03-30T04:00:00Z | 2010 | 3 | 2010-03-30T04:00:00Z | 2010-03-31T18:32:57Z | 2010-07095 | 0 | 0 | 0900006480acc25e | |
| FDA-2010-N-0001-0032 | FDA | FDA-2010-N-0001 | Advisory Committees; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-03-29T04:00:00Z | 2010 | 3 | 2010-03-29T14:47:46Z | 2010-06861 | 0 | 0 | 0900006480aca86c | ||
| FDA-2008-C-0098-0003 | FDA | FDA-2008-C-0098 | Listing of Color Additives Exempt From Certification: Bismuth Citrate | Rule | NFR-Notice of Final Rule | 2010-03-26T04:00:00Z | 2010 | 3 | 2010-04-26T04:00:00Z | 2010-04-22T16:10:20Z | 2010-06731 | 0 | 0 | 0900006480ac9372 | |
| FDA-1993-N-0259-0016 | FDA | Quality Standard for Foods With No Identity Standards; Bottled Water FDA-1993-N-0259 | Beverages; Bottled Water | Rule | Final Rule | 2010-03-24T04:00:00Z | 2010 | 3 | 2010-03-24T04:00:00Z | 2024-04-12T12:24:50Z | 96-6940 | 0 | 0 | 0900006480503ebc | |
| FDA-2010-N-0010-0001 | FDA | FDA-2010-N-0010 | Product Jurisdiction: Change of Address and Telephone Number; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-03-23T04:00:00Z | 2010 | 3 | 2010-03-23T04:00:00Z | 2010-03-23T15:23:04Z | 2010-06246 | 0 | 0 | 0900006480ac615b | |
| FDA-2010-N-0002-0023 | FDA | FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Flunixin | Rule | NFR-Notice of Final Rule | 2010-03-19T04:00:00Z | 2010 | 3 | 2010-03-19T14:36:48Z | 2010-06038 | 0 | 0 | 0900006480ac18f4 | ||
| FDA-1995-N-0259-0002 | FDA | Regulations Restricting the Sale & Distribution of Cigarettes & Smokeless Tobacco to Protect Children & Adolescents FDA-1995-N-0259 | Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco To Protect Children and Adolescents | Rule | NFR-Notice of Final Rule | 2010-03-19T04:00:00Z | 2010 | 3 | 2011-06-11T16:25:43Z | 2010-06087 | 0 | 0 | 0900006480ac184d | ||
| FDA-2010-N-0002-0022 | FDA | FDA-2010-N-0002 | Oral Dosage Form New Animal Drugs: Tetracycline Powder; Technical Amendment | Rule | NFR-Notice of Final Rule | 2010-03-18T04:00:00Z | 2010 | 3 | 2010-03-18T04:00:00Z | 2010-03-18T15:23:20Z | 2010-05925 | 0 | 0 | 0900006480ac0362 | |
| FDA-2010-N-0002-0016 | FDA | FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Zilpaterol | Rule | NFR-Notice of Final Rule | 2010-03-11T05:00:00Z | 2010 | 3 | 2010-03-11T15:33:43Z | 2010-05224 | 0 | 0 | 0900006480abaf98 | ||
| FDA-2009-N-0436-0003 | FDA | FDA-2009-N-0436 | Confirmation of Effective Date: New Animal Drug Applications | Rule | NCD-Notice of Confirmation of Effective Date | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T05:00:00Z | 2010-03-08T20:12:22Z | 2010-04923 | 0 | 0 | 0900006480ab81f2 | |
| FDA-2010-N-0002-0014 | FDA | FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor | Rule | NFR-Notice of Final Rule | 2010-03-05T05:00:00Z | 2010 | 3 | 2010-03-09T14:28:56Z | 2010-04560 | 0 | 0 | 0900006480ab5f5b | ||
| FDA-1992-N-0049-0028 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule | Rule | NFR-Notice of Final Rule | 2010-03-04T05:00:00Z | 2010 | 3 | 2010-03-04T05:00:00Z | 2010-03-08T06:09:32Z | 0 | 0 | 0900006480ab4f84 | ||
| FDA-1981-N-0114-0001 | FDA | Topical Acne Drug Product For Over-the-Counter Human Use FDA-1981-N-0114 | Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule | Rule | NFR-Notice of Final Rule | 2010-03-04T05:00:00Z | 2010 | 3 | 2011-06-11T16:25:43Z | 2010-04424 | 0 | 0 | 0900006480ab4db0 | ||
| FDA-2010-N-0002-0009 | FDA | FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Bacitracin Zinc; Nicarbazin | Rule | NFR-Notice of Final Rule | 2010-02-22T05:00:00Z | 2010 | 2 | 2010-02-22T05:00:00Z | 2010-02-23T13:57:08Z | 2010-03328 | 0 | 0 | 0900006480aa9b3b | |
| FDA-2009-N-0665-0085 | FDA | FDA-2009-N-0665 | New Animal Drugs; Change of Sponsor - Final Rule | Rule | Final Rule | 2010-01-20T05:00:00Z | 2010 | 1 | 2010-01-20T05:00:00Z | 2014-01-07T21:41:55Z | 2010-00930 | 0 | 0 | 0900006480a802fb | |
| FDA-2009-N-0665-0083 | FDA | FDA-2009-N-0665 | Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol and Flunixin | Rule | Final Rule | 2010-01-11T05:00:00Z | 2010 | 1 | 2014-07-11T16:33:22Z | 2010-00209 | 0 | 0 | 0900006480a7b385 | ||
| FDA-2009-N-0665-0080 | FDA | FDA-2009-N-0665 | Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium - Final Rule | Rule | Final Rule | 2010-01-11T05:00:00Z | 2010 | 1 | 2014-01-07T21:41:03Z | 2010-00207 | 0 | 0 | 0900006480a7b29f | ||
| FDA-2009-N-0665-0081 | FDA | FDA-2009-N-0665 | New Animal Drugs; Ractopamine - Final Rule | Rule | Final Rule | 2010-01-11T05:00:00Z | 2010 | 1 | 2014-01-07T21:43:54Z | 2010-00208 | 0 | 0 | 0900006480a7b2e7 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);